Literature DB >> 21875294

MTHFR polymorphisms and Opisthorchis viverrini infection: a relationship with increased susceptibility to cholangiocarcinoma in Thailand.

Nopparat Songserm1, Supannee Promthet, Paiboon Sithithaworn, Chamsai Pientong, Tipaya Ekalaksananan, Peechanika Chopjitt, Donald Maxwell Parkin.   

Abstract

Opisthorchis viverrini (OV) infection is the major risk factor for cholangiocarcinoma (CCA). Methylenetetrahydrofolate reductase (MTHFR) is an important enzyme in folate metabolism. Change in MTHFR activity may influence both DNA methylation and synthesis, crucial steps in carcinogenesis. This study aimed to investigate the association between MTHFR polymorphisms and OV infection with CCA risk in a high-incidence area of Thailand. A nested case-control study within cohort study was carried out: 219 subjects with primary CCA were matched with two non-cancer controls from the same cohort on sex, age at recruitment and presence/ absence of OV eggs in stool. At the time of recruitment information on consumption of foodstuffs potentially contaminated by OV was obtained by questionnaire. MTHFR polymorphisms were analyzed using PCR with high resolution melting analysis. Associations between variables and the risk of CCA were assessed using conditional logistic regression. Risk of CCA was related to consumption of a dish of raw freshwater fish (Koi- Pla) with clear dose-response effects, and there were joint effects on CCA risk between MTHFR polymorphisms and consumption of dishes containing raw- and/or semi-raw freshwater fish. This study provides evidence to support a relationship of increased susceptibility to CCA in individuals with MTHFR variants, especially for those individuals who have OV infection or consume semi-raw freshwater fish (acting either as a source of OV or of pre-formed nitrosamine). Folate may play an important role in OV-related cholangiocarcinogenesis by upsetting the balance between DNA methylation and synthesis in the folate pathway.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21875294

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  6 in total

Review 1.  The significance of genetics for cholangiocarcinoma development.

Authors:  Luca Maroni; Irene Pierantonelli; Jesus M Banales; Antonio Benedetti; Marco Marzioni
Journal:  Ann Transl Med       Date:  2013-10

2.  Ecohealth research in Southeast Asia: past, present and the way forward.

Authors:  Hung Nguyen-Viet; Siobhan Doria; Dinh Xuan Tung; Hein Mallee; Bruce A Wilcox; Delia Grace
Journal:  Infect Dis Poverty       Date:  2015-01-29       Impact factor: 4.520

3.  Gene-environment interaction involved in cholangiocarcinoma in the Thai population: polymorphisms of DNA repair genes, smoking and use of alcohol.

Authors:  Nopparat Songserm; Supannee Promthet; Chamsai Pientong; Tipaya Ekalaksananan; Peechanika Chopjitt; Surapon Wiangnon
Journal:  BMJ Open       Date:  2014-10-21       Impact factor: 2.692

Review 4.  Thinking beyond Opisthorchis viverrini for risk of cholangiocarcinoma in the lower Mekong region: a systematic review and meta-analysis.

Authors:  Jennifer A Steele; Carsten H Richter; Pierre Echaubard; Parichat Saenna; Virginia Stout; Paiboon Sithithaworn; Bruce A Wilcox
Journal:  Infect Dis Poverty       Date:  2018-05-17       Impact factor: 4.520

5.  Opisthorchiasis with proinflammatory cytokines (IL-1β and TNF-α) polymorphisms influence risk of intrahepatic cholangiocarcinoma in Thailand: a nested case-control study.

Authors:  Supannee Promthet; Nopparat Songserm; Somkiattiyos Woradet; Chamsai Pientong; Tipaya Ekalaksananan; Surapon Wiangnon; Akhtar Ali
Journal:  BMC Cancer       Date:  2018-08-23       Impact factor: 4.430

6.  Cholangiocarcinoma protective factors in Greater Mekong Subregion: Critical issues for joint planning to sustainably solve regional public health problems.

Authors:  Nopparat Songserm; Somkiattiyos Woradet; Waratip Kankarn; Kanjanar Pintakham; Phouthong Vanhnivongkham; Nguyen Thi To Uyen; Nguyen Cong Cuu; Le Ngoc Cua; Banchob Sripa; Akhtar Ali
Journal:  PLoS One       Date:  2022-01-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.